#infection control solutions | Explore Tumblr posts and blogs

laugtherhyena · 1 year ago

Note

Playlist listened to while writing; https://spotify.link/WzxvdTKBCJb

Holy shit dude, the ceo of rei angst wrote some rei angst what the HELL!! We have to kill her guys she cant keep getting away with this.

Anyways im gonna be writing about a lot of these nerds. I just love rei. This is really rushed and I am really sleepy so it is not my best writing.

Also i cannot write teruya so you will habe to ppppUT UP WITH IT.

Warnings for like. Violence and my attempt at writing a breakdown.

Rei held the rusty pipe like a baseball bat, swinging for a homerun as she smacked off the head of someone she once knew. Someone who had abandoned her long ago.

The rotting head of what used to be her mother rolled on the ground, sickly green skin squishing against the ground and stared up at her with lifeless eyes.

“I didn’t want to see you again like this,” Rei hissed as her chest heaved, “i wanted to see you staring with regret as you saw your daughter on top of the world. I didn’t want to kill you or see you dead.”

That had been the second time she had run into her zombified mother. The first, she had been a coward, unable to kill her and her father– the two people she hated most, the two people who had abandoned her and left her on the streets.

Where had all her rage gone that time. When had she become soft.

Midori clung to Ryutaro with all the strength in her frail body. “My brother,” she whispered, “i saw my brother’s corpse down there. Kakeru… he… they got Kakeru… they killed Kakeu…”

He didn’t say much in return, but he did pat her hand briefly– the only comforting action he could manage while carrying her.

“I see a store up ahead. Let’s stop by there for supplies.” Keisuke pointed out to the leader of the bunch.

Setsuka patted the clown on the back and gave him a smile. “Sounds good, lead the way. Maki, do you need me to carry Yamaguchi for a bit?”

Midori wrapped her arms and legs around Ryutaro a bit tighter at the suggestion, very much attached to the guy who had found her and saved her from zombies.

“I’ll be fine until we reach the stop.” The blonde nodded his acknowledgement to the bluenette, forcing a smile as he struggled to catch up.

The group walked in silence for a bit, the only sounds being the orchestra of distant zombie groans.

“Miss Yamaguchi,” Hikaru said after bit, his tone fatherly like usual, “may I check your pulse soon? And may I check if the swelling on your ankles has gone down?”

“Yeah, that… sounds good. Thank you, Uncle.”

Kanata removed the bandages from Ayame’s arm gradually.

“There isn’t any sign of infection, Hatano. Kinjo and Maki are still out, so… uhm… can I get you something to eat?” The surgeon spoke softly as she stared at the sprinter.

“I’m not hungry…” Ayame mumbled.

“Inori!” Tomori slammed the door open, her eyes sunken from lack of sleep, “i think i got bit. Check! Check, please!!”

Kanata bit back a sigh of exasperation and forced out her cheerful smile. “Of course. Where do you think you were bit this time?”

“My ankle. They went after my ankle so I couldn’t run! They’re going to eat me. I’m going to die, aren’t I? Oh, god, I’m going to die!” The cheerleader’s words were jumbled together and practically nonsensical. She grabbed onto Kanata’s shoulders as she spoke, her nails digging into the other’s lab coat and pressing her skin uncomfortably.

“Miss Tomori,” Kanata winced, “please let go of me. I will check your ankle, but I am sure you are fine.”

“I’m not fine!” Kizuna wailed before glaring accusatory daggers at Ayame. “If you… if you hadn't gotten yourself bitten! If you had just seen that bitch for what she is! We wouldnt be doomed! You’ve doomed us all!”

Ayame took the words without fighting back. What had been the point in fighting anymore? Kizuna was right. She had doomed them all.

“Miss Tomori, please… Taira had us all fooled… if Miss Hatano is to blame, then so are the rest of us…” the blonde murmured. “Please sit down so I can check your ankle…”

Mindless. Kinji was mindless. His faith had only been able to spare him for so long.

His teeth were decayed now. His skin was green and purple and yellow. His eyes were dull. His cheeks were sunken.

It was incredible that his mind stayed intact long enough for him to bury as many as he did. The only bodies he didn’t put 6 feet under, the only bodies he couldn’t handle burying, were those of the people he knew.

But what was the point?

Yuki held his stomach as he choked up and spat out the last meal he had, beans that had barelt even begun to digest.

“Urgh… gross…” he mumbled to himself.

Shinji was away at the moment, scouting out for the next safe place for them to go and likely trying to find his family in the process.

The lucky student fought back envious tears. At least they knew there was a chance that Shinji’s family was alive– they found his mother, Aiko, brutally murdered in the Maeda household. Her corpse was bloated and rotted when they found it.

The sight still haunted his dreams. He couldn’t even keep.meals down since he saw it.

Mikako peered into her brother’s lab. He hadn’t eaten in quite some time, nor had he slept.

“Yamato…” she whispered hesitantly.

He spun around with a dart ready in his hand. He only lowered it after he registered it was her.

“Mikako, I’ve told you to leave me alone. I need to find a cure, or no one will be safe.” The inventor turned back to his work and threw a crumpled up piece of paper to the side.

“I’m sure someone else is searching for a cure, Yamato. Why not try to make a vaccine? Some sort of immunity would help while someone else finds a cure.” The exorcist suggested.

Her brother didn’t seem to have heard. That, or he was ignoring her.

“Ah… nevermind.” She straightened her back and spun on her heel to hunt down their other classmates.

For the newcomers, Satsuki was putting on a performance– juggling empty bottles and broken gadgets whilst telling jokes. That could not be safe, but Haruhiko seemed to have his eyes on her.

The bunker door heaved open, and Teruya’s team came in, carrying boxes full of food and other supplies.

“We’re back with dinner!” The merchant shouted.

Mikako rushed over to take the box from him.

“Thank you, Otori, this should be good for at least a week. You and your scavenger team did good.”

He grinned at her and handed his box over. “Thanks! We uh…” he hesitated, “We saw Taira and Maeda… err… Utsuro? On our flight back… they looked like they were heading somewhere… dunno where…”

She bit her tongue and nodded thankfully at him. “Thank you for telling me.”

Thats it. Im hungry good bye.

Aw yeah infection Au moment! I do remember you saying a while back that you wanted to write something about Rei in this Au and MAN her part has gotta be my favorite out of these little snippets.

I really like taking a look at how a bunch of the cast is doing, seeing the way you wrote them in those situations was pretty fun! It reminded me how much i like the idea of Setsuka's like group with the 6.5 cast and how Kanata probably wishes she has a degree in psychology to properly deal with Ayame and Kizuna (she may feel as if she's not doing enough for them seing as her kindness can only bring her so far when dealing with their turmoil)

#i really like thinking about the voids + hibiki in this au too #i never explained this before because i wanted to draw something for it but oh well #basically at one point the voids (as in Nikei Hajime and Emma since Iroha has been zombified and ran away by now) steal some suplies from #Syobai's apocalypse mob. so he sends Kanade and Hibiki to “take care of them” for him #because Kanade has deal with Syobai where she's essentially works as his executor whenever he needs it #and in exchange he lets her take things rom his stocks when she pleases (she mainly takes weapons. the crazier the better)#and you know. Hibiki i in her puppet stage so she goes along #so the twins go after the voids in their mad max-esc apocalypse car and after a while Kanade manages to corner them #and Hibiki takes this opportunity to stab her in the back :) literally #because turns out Hibiki snapped out of her puppet stage at some point a while back. and seeing Kanades terrifying true nature #she wanted to put an end to her madness but for the time being she kept pretending to be under her control. because she wa looking for the #right opportunity to deal a killing blow without because Kanade is a better fighter than her #this opportunity turned out to be the voids! she explains the whole story to them and offers to do something for them to make up #for the hell Kanade and her put them through (chasing them around for several days and getting into fights)#so Hajime asks for her to hand over all of her supplies. Emma asks for the car. and Nikei asks her if she has any information about #a possible cure for the virus (because he feels somewhat guilty for what happened to Iroha) and Hibiki tells her she knows of a scientist #that's working on one and recives chemicals suplies from Syobai (because he wants this capitalize on this cure whenever it gets done)#So by Nikei's orders Hibiki tricks Mikado into giving her a stash of Kokoro's solution and goes with the voids in a search for Iroha #so that they can give her the prototype cure (which works just as a virus suppressant so far) before she reaches a stage where her mind is #too far gone. so overtime Hibiki essentially becomes a void member and she has friends again for the first time since forever #i like infection au Hibiki a lot. i had a sketch of her and Kanade somewhere i think #super danganronpa another 2 #danganronpa another #dra #sdra2 #zombie au #infection au #hyena ramblings

13 notes · View notes

dbmrsuresh · 11 days ago

Text

Bacterial Infection Diseases Market Insights: Growth, Share, Value, Size, and Analysis

"Global Bacterial Infection Diseases Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032

Executive Summary:

Global bacterial infection diseases market size was valued at USD 91.96 billion in 2024 and is projected to reach USD 176.63 billion by 2032, with a CAGR of 8.50% during the forecast period of 2025 to 2032.

Bacterial Infection Diseases Market Poised for Strong Growth Driven by Innovation and Evolving Demand

The global Bacterial Infection Diseases Market is witnessing accelerated growth as businesses adapt to changing consumer expectations, regulatory shifts, and rapid technological advancements. With increasing demand for efficient, scalable, and sustainable solutions, companies across various sectors are investing heavily in Bacterial Infection Diseases Market-related innovations. This upward trend is supported by the widespread adoption of digital tools, rising automation, and a stronger emphasis on data-driven strategies, positioning the Bacterial Infection Diseases Market as a key growth engine in the modern economic landscape.

A new comprehensive report offers detailed insights into the current state and future outlook of the Bacterial Infection Diseases Market, including market size, segment analysis, regional breakdowns, and competitive intelligence. The study also highlights critical trends such as consumer behavior shifts, sustainability initiatives, and emerging technologies that are shaping the industry. Designed for decision-makers, investors, and stakeholders, this report provides strategic recommendations to help businesses stay ahead in a dynamic and competitive environment.

Discover the latest trends, growth opportunities, and strategic insights in our comprehensive Bacterial Infection Diseases Market report.

Download Full Report: https://www.databridgemarketresearch.com/reports/global-bacterial-infection-diseases-market

Bacterial Infection Diseases Market Overview

**Segments**

- **Product Type**: The bacterial infection diseases market is segmented by product type into antibiotics, vaccines, and others. Antibiotics hold a significant share in the market due to their widespread usage in treating bacterial infections.

- **Disease Type**: Segmentation based on disease type includes urinary tract infections, respiratory infections, gastrointestinal infections, and others. Urinary tract infections represent a substantial portion of the market due to their high prevalence globally.

- **Distribution Channel**: The market is segmented by distribution channel into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies account for a large share as they are the primary source of antibiotics and other medications for bacterial infections.

- **Region**: Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the market due to the high prevalence of bacterial infections and well-established healthcare infrastructure.

**Market Players**

- **Pfizer Inc.**: A leading player in the bacterial infection diseases market, Pfizer offers a wide range of antibiotics and vaccines for various bacterial infections.

- **Merck & Co., Inc.**: Merck is a key player known for its innovative research and development in the field of bacterial infection treatments.

- **GlaxoSmithKline plc**: This pharmaceutical giant has a strong presence in the market with a diverse portfolio of antibiotics and vaccines.

- **Novartis AG**: Novartis is actively involved in developing new treatments for bacterial infections, contributing to its market position.

- **Sanofi**: Sanofi is a prominent player offering effective solutions for bacterial infection diseases through its product offerings.

The global bacterial infection diseases market is witnessing steady growth driven by the increasing incidence of bacterial infections worldwide. The rise in antibiotic-resistant bacteria is a significant challenge in the market, driving the need for innovative treatment options. The market players mentioned above are actively engaged in research and development activities to address this challenge and introduce novel therapies.

Moreover, the market segmentation based on product type, disease type, and distribution channel provides insights into the specific areas of growth within the bacterial infection diseases market. With the increasing awareness about preventive healthcare measures and the rising investments in healthcare infrastructure in emerging economies, the market is poised for further expansion.

https://www.databridgemarketresearch.com/reports/global-bacterial-infection-diseases-market The global bacterial infection diseases market is undergoing significant transformations due to the emergence of novel technologies and therapies that are reshaping the treatment landscape. In recent years, there has been a growing emphasis on precision medicine approaches, tailored diagnostics, and targeted therapies for bacterial infections. Market players are focusing on advancing their research capabilities to develop more effective treatment options that can combat antibiotic resistance and improve patient outcomes. Collaborations between pharmaceutical companies, healthcare institutions, and research organizations are fostering innovation and driving the development of new antibiotics and vaccines.

One of the key trends shaping the bacterial infection diseases market is the increasing adoption of combination therapies to address complex infections and multidrug-resistant strains of bacteria. By combining different classes of antibiotics or using synergistic drug combinations, healthcare providers can enhance treatment efficacy and reduce the likelihood of resistance development. This approach aligns with the concept of personalized medicine, where treatments are customized based on individual patient characteristics and infection profiles.

Another significant trend in the market is the shift towards preventive strategies and infection control measures to reduce the incidence of bacterial infections. Healthcare stakeholders are placing greater emphasis on vaccination programs, antimicrobial stewardship initiatives, and hygiene protocols to limit the spread of infectious agents and curb the rise of resistant bacteria. Additionally, the integration of digital health technologies, such as telemedicine platforms and remote monitoring systems, is enhancing the delivery of care for patients with bacterial infections and improving treatment adherence.

The market landscape for bacterial infection diseases is highly competitive, with leading players investing heavily in research and development to maintain their competitive edge. Product innovation, regulatory approvals, and strategic partnerships are critical factors influencing the market dynamics and shaping future growth opportunities. As healthcare systems worldwide grapple with the challenges posed by infectious diseases, the demand for effective antibacterial treatments is expected to remain robust, driving continued investments in the development of novel therapeutic agents and diagnostics.

Overall, the global bacterial infection diseases market is poised for significant growth in the coming years, propelled by evolving treatment paradigms, increasing disease burden, and the pursuit of precision medicine approaches. By leveraging advances in science, technology, and collaborative partnerships, market players can address the unmet medical needs of patients with bacterial infections and contribute to the advancement of public health initiatives globally.**Segments**

Global Bacterial Infection Diseases Market: - Types: The bacterial infection diseases market includes segments such as Bacterial Skin Infections, Foodborne Bacterial Infections, Sexually Transmitted Bacterial Infections, and Others. Each type represents a specific area of bacterial infection prevalence and treatment. - Treatment: The market offers various treatment options including medication, therapy, and others to combat bacterial infections effectively. - Diagnosis: Diagnosis methods for bacterial infections include Blood Tests, Imaging Studies, and others to accurately identify the presence of bacterial pathogens. - Route of Administration: Different routes of administration such as Oral, Topical, Parenteral, and others are utilized for the delivery of antibacterial treatments. - End-Users: Hospitals, Specialty Clinics, Homecare, and Others are the primary end-users of bacterial infection treatment services. - Distribution Channel: The market distribution channels include Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others for the convenient availability of antibacterial medications.

**Market Players** - Eli Lilly and Company (U.S.) - AstraZeneca (U.K.) - Novartis AG (Switzerland) - Johnson & Johnson Private Limited (U.S.) - Teva Pharmaceutical Industries Ltd. (Ireland) - Merck & Co., Inc. (U.S.) - Allergan (Ireland) - Bausch Health Companies Inc. (Canada) - Abbott (U.S.) - F. Hoffmann-La Roche Ltd. (Switzerland) - Pfizer Inc. (U.S.) - GlaxoSmithKline plc (U.K.) - Sanofi (France) - Merck KGaA (Germany) - Sun Pharmaceutical Industries Ltd. (India) - Endo International plc (Ireland) - Apotex Inc. (Canada) - Amneal Pharmaceuticals LLC. (U.S.) - Fresenius Kabi AG (Germany) - Torrent Pharmaceuticals Ltd. (India)

The global bacterial infection diseases market is dynamic, driven by factors such as the prevalence of bacterial infections, antibiotic resistance, and advancements in treatment options. The market segments help in understanding the specific areas of growth within the industry, ranging from different types of infections to varied treatment options and distribution channels.

The market players in bacterial infection diseases are crucial in driving innovation and research to combat the challenges posed by bacterial pathogens. Companies like Pfizer Inc., GlaxoSmithKline plc, and Novartis AG are investing heavily in R&D to develop new antibiotics and vaccines to address antibiotic-resistant strains and enhance patient outcomes.

The market landscape is competitive, with companies focusing on product innovation, partnerships, and regulatory approval to stay ahead. The trend towards personalized medicine and preventive strategies is reshaping the market dynamics, emphasizing the importance of tailored treatments and infection control measures.

Collaborations within the healthcare sector are fostering innovation and the development of novel therapeutic agents and diagnostics. Digital health technologies are also playing a significant role in improving the delivery of care for patients with bacterial infections, promoting treatment adherence, and monitoring.

Overall, the global bacterial infection diseases market is on a trajectory of growth, driven by evolving treatment paradigms, increasing disease burden, and the pursuit of precision medicine approaches. The market players mentioned above are at the forefront of these advancements, contributing to the overall improvement of public health initiatives globally.

The Bacterial Infection Diseases Market is highly fragmented, featuring intense competition among both global and regional players striving for market share. To explore how global trends are shaping the future of the top 10 companies in the keyword market.

Learn More Now: https://www.databridgemarketresearch.com/reports/global-bacterial-infection-diseases-market/companies

Regional Outlook

North America: The Bacterial Infection Diseases Market in North America is driven by advanced technological infrastructure, strong consumer demand, and supportive government policies. The United States holds the largest share due to early adoption and robust investment.

Europe: Europe showcases steady growth in the Bacterial Infection Diseases Market, supported by strict regulatory frameworks, sustainability initiatives, and innovation-led economies. Key contributors include Germany, the U.K., and France.

Asia-Pacific: Asia-Pacific is the fastest-growing region for the Bacterial Infection Diseases Market, fueled by population growth, urbanization, and industrial expansion. China, India, and Japan are major markets with high potential.

Latin America: Growth in Latin America is moderate but rising, driven by expanding middle-class populations and increasing awareness of Bacterial Infection Diseases Market applications. Brazil and Mexico are the leading countries.

Middle East & Africa: The Bacterial Infection Diseases Market in this region is gaining momentum due to infrastructural developments, diversification efforts, and rising investments. The UAE, Saudi Arabia, and South Africa are key players.

Competitive Landscape

Eli Lilly and Company (U.S.), AstraZeneca (U.K.), Novartis AG (Switzerland), Johnson & Johnson Private Limited (U.S.), Teva Pharmaceutical Industries Ltd. (Ireland), Merck & Co., Inc. (U.S.), Allergan (Ireland), Bausch Health Companies Inc. (Canada), Abbott (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Sanofi (France), Merck KGaA (Germany), Sun Pharmaceutical Industries Ltd. (India), Endo International plc (Ireland), Apotex Inc. (Canada), Amneal Pharmaceuticals LLC. (U.S.), Fresenius Kabi AG (Germany), Torrent Pharmaceuticals Ltd. (India)

Future Trends— Global Bacterial Infection Diseases Market

Upcoming Technologies: The Bacterial Infection Diseases Market will witness rapid adoption of cutting-edge technologies such as artificial intelligence, machine learning, the Internet of Things (IoT), blockchain, and automation. These technologies are expected to enhance operational efficiency, enable real-time data-driven decisions, and introduce innovative products and services.

Consumer Behavior Changes: The Bacterial Infection Diseases Market will be shaped by changes in consumer preferences toward offerings that are experience-driven, convenient, and personalized. Increasing demand for transparency, digital engagement, and value-driven purchases will push companies to innovate their marketing and product strategies.

Sustainability Trends: Sustainability will be a critical focus, with consumers and regulators alike driving demand for eco-friendly materials, energy-efficient processes, and circular economy initiatives. Businesses are anticipated to prioritize green innovations to reduce carbon footprints and meet stricter environmental regulations.

Expected Innovations: The market is expected to see significant innovations, including smart products, integration of advanced analytics for predictive insights, and development of new materials or solutions tailored to emerging needs. Collaboration between technology firms and industry leaders will accelerate these innovations.

Why This Report is Valuable

This report provides in-depth industry insights that help stakeholders understand the current market landscape, key drivers, challenges, and growth opportunities within the Bacterial Infection Diseases Market. It offers regional and segment-wise forecasts that enable precise market planning and targeted investment strategies tailored to specific geographic areas and product/service segments.

The report includes comprehensive competitor benchmarking, allowing businesses to evaluate their position relative to key players, understand competitive strategies, and identify gaps or opportunities for differentiation. Additionally, it delivers actionable strategic recommendations based on market trends and data analysis to support informed decision-making, optimize business growth, and enhance market presence.

Top 15 FAQs About the Global Bacterial Infection Diseases Market Research Report

What key segments are analyzed in the Bacterial Infection Diseases Market report?

Which regions show the highest growth potential in the Bacterial Infection Diseases Market ?

What time frame does the Bacterial Infection Diseases Market report cover for forecasts?

What are the major drivers influencing the growth of the Bacterial Infection Diseases Market?

Who are the leading competitors in the Bacterial Infection Diseases Market?

How is market size estimated for the Bacterial Infection Diseases Market?

What research methodologies are used to compile the Bacterial Infection Diseases Market report?

Does the report discuss regulatory impacts on the Bacterial Infection Diseases Market?

Are emerging technologies covered in the Bacterial Infection Diseases Market analysis?

How does consumer behavior affect the Bacterial Infection Diseases Market trends?

What sustainability trends are impacting the Bacterial Infection Diseases Market?

Does the report include a SWOT analysis of key players in the Bacterial Infection Diseases Market?

How frequently is the Bacterial Infection Diseases Market report updated?

Can the Bacterial Infection Diseases Market report be customized for specific business needs?

What are the future opportunities and challenges identified in the Bacterial Infection Diseases Market?

Browse More Reports:

https://www.databridgemarketresearch.com/es/reports/north-america-digital-experience-platform-markethttps://www.databridgemarketresearch.com/pt/reports/north-america-ivd-regulatory-affairs-outsourcing-markethttps://www.databridgemarketresearch.com/de/reports/north-america-cigarette-filters-markethttps://www.databridgemarketresearch.com/es/reports/global-balloon-expandable-stents-markethttps://www.databridgemarketresearch.com/ru/reports/north-america-gamma-butyrolactone-market

About Data Bridge Market Research:

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us: Data Bridge Market Research US: +1 614 591 3140 UK: +44 845 154 9652 APAC : +653 1251 975 Email:- [email protected]

Tag

Bacterial Infection Diseases Market Size, Bacterial Infection Diseases Market Share, Bacterial Infection Diseases Market Trend, Bacterial Infection Diseases Market Analysis, Bacterial Infection Diseases Market Report, Bacterial Infection Diseases Market Growth, Latest Developments in Bacterial Infection Diseases Market, Bacterial Infection Diseases Market Industry Analysis, Bacterial Infection Diseases Market Key Player, Bacterial Infection Diseases Market Demand Analysis"

#Bacterial Pathogen Treatment Market #Infectious Disease Management Market #Antibacterial Drug Market #Antibiotic Resistance Solutions Market #Bacterial Sepsis Therapy Market #Microbial Disease Control Market #Pathogenic Bacteria Treatment Market #Gram-Positive & Gram-Negative Infection Market #Zoonotic Bacterial Diseases Market #Hospital-Acquired Infections Market

0 notes

utopiasingapore · 2 months ago

Text

Infection Control in Healthcare: The Role of Utopia-Aire Isolation Rooms in Singapore

The Importance of Infection Control in Healthcare Facilities

Contagious infections pose a serious challenge to healthcare all around the world. In Singapore, the healthcare infrastructure is advanced and patient care is a priority, yet Infection Control remains a critical concern in hospital management. Hospitals and clinics are expected to implement stringent measures to prevent the spread of contagious diseases, ensuring a safe environment for both patients and healthcare professionals.

At Utopia, we are committed to transforming infection control in Singapore by providing cutting-edge solutions such as Utopia-Aire Isolation Rooms. Our advanced technologies help hospitals and medical facilities maintain the highest standards of hygiene and patient safety, reducing the risk of disease transmission.

Why Infection Control Matters

Think about this: You walk into a hospital expecting to get better, but what if you leave sicker than when you arrived? That’s exactly what happens when Infection Control measures fail! Diseases like Tuberculosis (TB) spread rapidly through the air when an infected person coughs. Without proper containment, these germs can infect anyone nearby. This is why hospitals must go beyond basic hygiene and invest in specialized solutions like Utopia-Aire Isolation Rooms.

Utopia-Aire Isolation Rooms: Protecting Singapore’s Healthcare Facilities

At Utopia, we understand that keeping infections contained is not just about protecting patients — it’s about safeguarding entire communities. Utopia-Aire Isolation Rooms are designed to keep contagious diseases like TB, flu, and even COVID-19 under control.

How Do Isolation Rooms Work?

Ever noticed how some rooms in hospitals feel like they’re “sucking” in air? That’s negative air pressure at work! Utopia-Aire Isolation Rooms use this advanced technology to ensure that contaminated air doesn’t escape into other parts of the hospital. Here’s how:

• Air is pulled into the room instead of flowing out. • The air is then filtered through high-efficiency particulate air (HEPA) filters. • Clean, safe air is released back outside, keeping infections isolated.

This technology creates a protective shield that prevents diseases from spreading, making infection control in Singapore more effective than ever before.

Essential Infection Control Practices in Singapore’s Healthcare System

Hospitals cannot rely on isolation rooms alone. A comprehensive infection control plan includes:

1. Hand Hygiene: The First Line of Defense Did you know that 80% of infections are spread by touch? Washing hands properly with soap and water or using alcohol-based sanitizers can cut infection rates in half.

2. Personal Protective Equipment (PPE) Doctors and nurses suit up with masks, gloves, gowns, and face shields to create a physical barrier against infections. Proper use and disposal of PPE are crucial.

3. Cleaning & Disinfection: Killing Germs Where They Hide Hospitals are germ hotspots! Every surface — from bed rails to door handles — needs to be disinfected regularly to stop bacteria and viruses in their tracks.

4. Air Filtration Systems: Breathing Clean, Safe Air Besides isolation rooms, hospitals use HEPA filters to capture airborne particles and prevent infections from spreading through ventilation systems.

5. Waste Disposal: Out of Sight, Out of Danger Used needles, contaminated materials, and infected waste must be properly disposed of to prevent cross-contamination.

Utopia’s Role in Elevating Infection Control in Singapore

Singapore has one of the world’s most advanced healthcare systems, and Utopia is at the forefront of making it even better. By integrating cutting-edge infection control technologies, we ensure that hospitals, clinics, and medical facilities stay one step ahead of infectious diseases.

We believe that healthcare should not be a risk — it should be a place of healing. Our innovative Utopia-Aire Isolation Rooms and air filtration solutions provide the protection that patients and healthcare workers need.

Final Thoughts: Stay Safe, Stay Protected

Infectious diseases aren’t going away, but with strong infection control measures, we can keep them contained. At Utopia, we’re not just providing technology — we’re providing peace of mind. Whether it’s through Utopia-Aire Isolation Rooms or cutting-edge air filtration, we’re dedicated to making Singapore’s hospitals safer for everyone. Because at the end of the day, infection control isn’t just about stopping diseases — it’s about saving lives.

In Order To Find Out More Details On Infection Control Singapore Please Be Touch With Us Today Onwards..!

#Infection Control #Infection Control Singapore #Infection Control Solution #Infectious Disease Treatment Room #bio-decontamination #cleanroom equipments #cleanroom construction materials #cleanroom products #bsc bio-safety laboratory equipments #operating room/ surgical room #cleanroom equipments singapore #bio-decontamination singapore

0 notes

miradorhealth · 1 year ago

Text

#Hand Hygiene Monitoring #Hand Hygiene Reporting #Hand Hygiene Solutions #Hand Sanitizing #Hand Sanitization Monitoring #Dispensing Solutions #Infection Prevention #Infection Control #HAI Prevention #Patient Safety #Clinical Staff Safety #Clinical Operations #Healthcare Automation #Healthcare IT #Behavioral Change Management #Healthcare Compliance Management #Healthcare Technology #SaaS #Agile Technology Solutions

0 notes

pharmanucleus1 · 1 year ago

Text

Antimicrobial Susceptibility Market: Precision in Pathogen Control

Antimicrobial Susceptibility Testing Market

The worldwide antimicrobial susceptibility testing market is expected to increase at a 5.5% CAGR from 2022 to 2027, from an anticipated value of US$3.6 billion in 2022 to US$4.7 billion in 2027. The Antimicrobial Susceptibility Testing (AST) Technology Market is expanding due to factors such as rising infectious illness prevalence, increased antibiotic resistance, and favourable government measures to minimise infectious disease burden. Antibiotic susceptibility testing is becoming more popular due to the rising prevalence of certain illnesses, such as bloodstream infections and pneumonia caused by E. coli, K. pneumonia, and P. aeruginosa, among others.

Click here for full report:

https://www.pharmanucleus.com/reports/antimicrobial-susceptibility-market

Antimicrobial Susceptibility Testing Market Dynamics

Drivers: Emergence of multidrug resistance due to drug abuse

The rise of drug resistance poses a significant threat to global health, particularly in the context of antibiotics. Antibiotics are becoming less effective as drug-resistant strains of bacteria spread worldwide. This has profound implications for disease treatment, as it makes infections more difficult to treat and ultimately increases mortality rates.

The World Health Organization (WHO) has identified drug-resistant pathogens, such as carbapenem-resistant gram-negative bacteria, as a major concern. Urgent development of new drugs is necessary to combat these infections effectively. However, without a fundamental change in the way antibiotics are used, the effectiveness of these new treatments may be compromised.

Misuse and overuse of antibiotics contribute to the development of drug resistance. Factors such as inappropriate prescribing, improper self-medication, and the use of antibiotics in livestock and agriculture all contribute to the problem. These practices create an environment where bacteria can adapt and develop resistance mechanisms, rendering antibiotics less effective over time.

To preserve the efficacy of antibiotics, it is crucial to promote responsible antibiotic use. This includes raising awareness among healthcare providers and the general public about appropriate antibiotic prescribing and the importance of completing prescribed courses of treatment. Additionally, robust regulations and surveillance systems are needed to monitor antibiotic use in various sectors, including healthcare, agriculture, and veterinary medicine.

Efforts to develop new antibiotics should be complemented by strategies to optimize their use, such as antibiotic stewardship programs and infection prevention and control measures. Research into alternative treatment options, such as phage therapy and immunotherapies, is also essential to diversify the arsenal against drug-resistant bacteria.

Opportunities: Growth opportunities in emerging market

The antimicrobial susceptibility testing market players are poised with significant opportunities in developing countries such as APAC (Asia-Pacific), India, China, and Japan. These countries are experiencing a notable growth in the antimicrobial susceptibility testing market, driven by several factors.

Firstly, the booming medical tourism industry in these regions attracts a large influx of patients seeking healthcare services, including diagnostics. This surge in medical tourism creates a demand for antimicrobial susceptibility testing as part of the diagnostic process.

Secondly, the adult population (over 20 years old) is growing in these countries, leading to a higher prevalence of infectious diseases. As a result, there is an increased need for accurate and timely antimicrobial susceptibility testing to guide appropriate treatment decisions.

Additionally, the increasing use of drugs in these regions contributes to the demand for antimicrobial susceptibility testing. With a growing population and expanding healthcare access, the requirement for testing to guide optimal drug selection and treatment outcomes becomes crucial.

Moreover, these countries possess a strong and skilled workforce that is well-versed in high technology. This skilled workforce plays a vital role in the successful implementation and operation of advanced antimicrobial susceptibility testing technologies, ensuring accurate and reliable results.

Furthermore, the relatively lax import/export laws in these regions provide an advantageous environment for market players to expand their brands and offerings. The underdeveloped nature of certain areas in these countries presents opportunities for companies to introduce and establish their technologies, filling gaps in the market and addressing unmet needs.

The growing number of technicians and their desire to learn and adopt new technologies further contribute to the development and updating of antimicrobial susceptibility testing capabilities in these regions, fostering innovation and advancements in the field.

Click here for full report:

https://www.pharmanucleus.com/reports/antimicrobial-susceptibility-market

Challenges: Complex Regulatory Frameworks

One of the major challenges in antibiotic susceptibility testing is the time gap between establishing clinical thresholds, obtaining regulatory approval for innovative antimicrobial treatments, and bringing those drugs to market. The process of gaining approval for new drugs involves stringent guidelines set by regulatory bodies like the FDA, which can result in significant delays.

The lack of established clinical thresholds for certain drugs further complicates the use of products aimed at increasing the susceptibility of microorganisms. Clinical thresholds are important benchmarks used to determine the effectiveness and appropriate usage of antimicrobial therapies. In some cases, such as invasive mold infections other than Aspergillus, the efficacy of antifungal therapy cannot be accurately assessed without the availability of specific clinical thresholds.

This time lag and absence of clinical thresholds can hinder the timely utilization of innovative antimicrobial treatments. It delays access to potentially life-saving therapies and limits healthcare professionals' ability to make informed decisions regarding treatment choices. The gap between setting clinical thresholds, regulatory approval, and market availability needs to be addressed to ensure that effective antimicrobial treatments reach patients in a timely manner and contribute to the fight against drug-resistant microorganisms.

Click here for request free sample:

https://www.pharmanucleus.com/request-sample/1193

Restraints: High Cost of automated Laboratory Instruments

Automated equipment for antimicrobial laboratories is quite expensive and offers premium features and functionality. The introduction of automated AST systems shortens incubation and detection times. Another barrier to this market is the high maintenance cost of these devices, which come with the latest software and require regular maintenance.

#antimicrobial susceptibility #pathogen control #infection management #precision medicine #microbial resistance solutions

0 notes

crazeno · 3 months ago

Text

HI i come baring an au i’ve been stupid ab and lowkey forgot i had tumblr and can share it here

A very basic summary so sorry for the plot holes and shitty wrriting

> CRYOGENIC AU

> Thousands upon thousands of years into the cybertronian war, Decepticon Mad Scientist, Shockwave, revealed his new experiment to dictator, Megatron, in hopes it would wipe out the Autobot faction for good. An infectious Bio-weapon dubbed the “Hate Plague” was unleashed onto the unknowing war soldiers.

> A violent virus spread through a prolonged touch, of which the infected would succumb to severe amounts of agitation, a loss of control and morality, as well as exhibiting violent behaviours towards any other life forms.

> Quickly they exhibited aggression towards each other, hoping the Autobots would tear their own faction apart. However the plague backfired, quickly advancing through cybertronian kind, both factions finding themselves trapped.

> Autobot inventor, Wheeljack, quickly explained the situation to the autobot commanders, having found a momentary solution to the virus during recent encounters, Cold Temperatures, a drop in the atmospheres temperature would halt the spread of the plague on an individual, but would not reverse the effects. Information that could be crucial in reversing the outbreak. But a task as such would be almost impossible with the large spread around the planet.

> The Decepticon faction had been completely overrun in attempt to fight back against the virus. Megatron reluctantly fleeing from the war grounds to save his own life, finding the remaining alive Autobots with their base in a secure lockdown.

> In a last ditch effort and attempt to prevent further bloodshed amidst the pandemic, Optimus Prime and Megatron formed an uneasy alliance, the raging war between the two factions had been shattered.

> Inventor Wheeljack believed he would be able to overcome the virus with a cure, but the current outbreak conditions on cybertron would make time and work near impossible.

> Optimus prime reluctantly left Cybertron, taking a handful of remaining autobot survivors, Megatron and what early stage infected bots they could safely secure with them, locked away in a frozen stasis.

> The first movements were rather slow, with little time to prepare their travel, energon and resources started to dwindle to dangerous levels, the crew travelling through the vast space for a safe place to land, until eventually crash landing on a near deserted frozen planet, Earth (1 million BCE), where they would be able to safely study and work towards curing the plague, as well as keep their energon stocked and collect resources to fix their ship and hopefully restore their dying planet.

With blood and rage of crimson red ripped from a corpse so freshly dead.

#transformers #transformers g1 #maccadams #maccadam #transformers au #tfcyrogenicau #megop #shh #crazenoposting

807 notes · View notes

starsthatlinethesky · 7 months ago

Text

What’s so fucking ironic about Jimmy in mouthwashing, is when he’s pitching a fit to Anya about having to do FIVE tasks around the ship when she asks for help with Curly’s medication and literally nobody actually ASKED him to do those things, there all pretty much self-imposed tasks.

Like an ACTUAL Captain would do these things with almost no complaint as he understands that they benefit not only himself but the safety and wellbeing of the crew.

But Jimmy can only see the rest of the crew as burdens and he is the sole person managing to keep this ship together with what he’s been given to work with. When that is so NOT the case.

Anya was most likely putting in so much work into keeping Curly alive, which in itself is a miracle seeing that state that he was in and the limited resources that the had. She had to find a way to provide nutrition, prevent infection and bleeding and somehow perform four amputations with what was most likely limited training from Pony Express. All while being PREGNANT.

Daisuke and Swansea were most likely the only thing keeping that ship running and preventing any further mechanical failures that could have put them all at further risk. As well as most likely actively looking for solutions to try and get parts of the ship running again.

And asking Daisuke to go in to the damaged vent when he KNEW it would do more harm than good to, was a risk that a captain would not take. And no, he wasn’t concerned about Anya when he asked Daisuke to go into the vent and I could argue that he wasn’t all that concerned about Curly either.

The only thing that he was concerned with was the fact that he had lost control of the situation and that Anya wasn’t being subservient to him and his demands.

Also the fact that he used the alcohol disinfectant to make that drink from Swansea also proved how little he thinks through his actions and the long term consequences. If he hadn’t of used it for the drink, it’s likely that it could have been used as a disinfectant for Daisuke’s wounds and could have also been rationed for other wounds the crew obtains as well.

But Jimmy can’t see the big picture, all Jimmy can see is all the messes and problems in the ship. That he CREATED. But he takes no responsibility for them as he can only think of what Jimmy wants and not how what he says or does impacts anyone else.

It’s just goes to show that Jimmy, is and has probably always been someone who wants the title and authority of a position like ‘Captain’ but he can’t handle any of the duties that come with it.

#mouthwashing #jimmy mouthwashing #anya mouthwashing #swansea mouthwashing #daisuke mouthwashing #curly mouthwashing #sorry for the rant

1K notes · View notes

damon25 · 4 months ago

Text

Multi-Purpose Telemetric I.V. Gowns: Enhancing Patient Care and Monitoring

Medical professionals now use Multi-purpose telemetric IV gowns for continuous patient monitoring as an innovative solution that enhances both patient care quality and comfort while enabling real-time monitoring capabilities. Specialized gowns equipped with telemetric functions enable easy intravenous (IV) treatment access, which makes them necessary for contemporary healthcare environments. Hospital gowns with IV access and telemetry pockets surpass traditional hospital gowns because their design includes features for continuous patient monitoring and IV line administration. Modern patient care benefits from telemetry pockets and sensor-friendly fabric that enables medical staff to track patient vital signs through monitoring devices while maintaining comfort for the patient. The gowns include carefully designed openings that will allow easy access to IV lines so healthcare providers do not need to remove the gown during treatment procedures. The main advantage of multi-purpose telemetric IV gowns is that they enhance the quality of care experienced by patients. The gowns offer comfort to long-term medical patients because they are made of soft, breathable, hypoallergenic materials. These garments with wrap-around or overlap designs ensure privacy while enabling quick medical staff access to examinations and interventions. Medical institutions obtain multiple advantages from these gowns because they improve workflow processes, minimize patient interruptions, and maintain optimal hygiene practices. These products exist in reusable and disposable versions to meet different needs throughout medical facilities, including intensive care units and outpatient areas. Healthcare institutions achieve improved patient safety while delivering accurate monitoring and maintaining patient dignity through the implementation of advanced patient-monitoring hospital gowns in their patient care practices.

#patient monitoring technology #hospital gown innovations #real-time vital sign tracking #medical wearables #smart hospital gowns #telemetry-enabled patient gowns #intravenous access clothing #healthcare workflow efficiency #patient-centered hospital apparel #infection control hospital gowns #ICU patient monitoring solutions #wearable health monitoring systems #advanced medical textiles #breathable hospital garments #hypoallergenic patient gowns

0 notes

sanitisposts · 2 years ago

Text

Choose the Best Infection Control Solutions | Sanitis

Sanitis is your go-to supplier for the best infection control products and state-of-the-art medical equipment. Because of our dedication to quality, healthcare workers and patients are protected in safer settings. Sanitis is at the forefront of protecting healthcare institutions with cutting-edge technologies and a focus on health and safety.

#Infection Control Solutions

0 notes

koolades-world · 5 months ago

Text

being sick sucked. the only good part about being sick in the devildom was not being able to infect anyone other than solomon, and the extended breaks you got after you came down with something.

one of the many privileges you were given was full control the the tv in the living room. you'd been sick a couple times while in the devildom at this point, so the brothers had already had their major freakouts over minor things. you were in the ideal stage of being sick right now: the brothers were still unsure enough to know if you were exaggerating your symptoms (to get what you wanted, of course!) but sure enough to know you're not about to keel over and die.

it was a saturday, and everyone was home. you didn't go to rad the past few days because you came down with something solomon had contracted while off in the depths of the devildom. nobody really knew what it was, but the most notable symptom was that your sweat now sparkled. it was only a little alarming to lucifer and barbatos, but since they couldn't figure out what the hell solomon had given you, they deemed rest to be the most appropriate solution. however, to you, this was the only sign you needed to put on the twilight saga.

at first, only asmo seemed interested in actually watching it with you. he'd somehow never seen it, so you quickly put it on. asmo was bundled in one of the many blankets that surrounded you at all times, while you sat in the middle of the nest, sweating- half because you were constantly overheating, and half because you were watching twilight.

mammon passed by the living room several times while completing tasks around the house, and made comments about the movie every single time. it was "this movie is stupid" and "yer seriously still watchin' this?" at first. then, it morphed into him lingering just behind the couch you were seated on, holding something he was in the middle of polishing. when you'd turn back to look at him, he'd pretend he wasn't paying attention whatsoever. when you finally invited him to join after catching him staring for the fifth time, and patted the seat besides you, he objected quickly, claiming "ya can keep yer vampire slop."

he returned in five minutes.

when beel got home from his workout, he tried to join you right away. asmo made him go take a shower first, which you felt hypocritical agreeing with. your oddly sparkly sweat stained whatever fabric it came into contact with. once the sweat evaporated, the sparkles were the only thing left behind.

once jasper came onto screen, mammon made a comment about his stare reminded him of lucifer's. you and asmo burst out laughing harder than you'd laughed in a long time. unfortunately for mammon, lucifer happened to be walking by at that very moment. you managed to talk lucifer out of punishing mammon when you claimed he was helping you out as your emotional support demon. sweating sparkles for an unknown reason was stressful work, after all.

satan walked by with a thick book, and promptly paused once he saw what you were watching. he'd read, and loved the books. he shoved mammon aside to sit next to you, so the two of you could excitedly chatter about the movie and book differences.

once the part where edward sparkled in the middle of the forest came on screen, you dramatically reenacted it in the middle of your living room, while getting beel to hold a flashlight over your head. you had the entire living room doubled over laughing, making the exertion worth it. the only one sensible to ask you to sit back down was lucifer, who had decided to watch the movie by standing at the back of the room, and denying that he even was. and upon seeing the baseball scene, all the brothers present (minus lucifer) wanted to do that immediately.

oh boy, what had you started?

#yes i did listen to bella's lullaby while writing this LMAO #not sick rn and hoping i'm not jinxing it with this #gn reader #drabble #obey me #obey me!#obey me x reader #obey me shall we date #obey me! shall we date #omswd #obey me! shall we date?#obey me asmo #obey me mammon #obey me satan #obey me lucifer #obey me beel

398 notes · View notes

diejager · 2 years ago

Note

Nooo but there is something about the monster au where there is a casual mention from her that she won't live as long as them (I assume monsters/hybrids are longer lived plus she is a lot more likely to die on mission), like she probably just jokes about it offhandedly and it sends all of them feral because... no? Absolutely not? Insulting. Ridiculous. Not happening.

Cue ultimate clinginess, all rushing to be more intimate because the thought of her not being around is abhorrent. Soap maybe losing it a bit going off on a line of thought about how he could mate her right? Would it be awful if there was a way for her to be a wolf shifter?

I AM GOING TO LOSE MY MIND

Change cw: mention of turning, mention of death, joking about death, tell me if I missed any.

All options are on the table at this point, death had always been something that loomed over them like a shadow, the veil and sickle of death following you wherever you went. You’ve had more than one reminder of your short life, your vulnerability as a human, weak and tender skin, short lives and a delicate body. There were so many things in the world that could pose a possible danger to you and they hated that.

You lived shorter lives than most monsters or hybrids, you grew sick and frail whereas hybrids could fight any viral infections or diseases, you didn’t have thicker skin despite all the extra layers of protective gear and you were a target of many for your choice of career. They were reminded of you mortality whenever you get hurt, blood painting your skin with a strong, metallic odour.

And it didn’t help that you’d often joke about it, throwing offhanded comments that made their hackles raise, body tense and mind brewing with what ifs scenario that has them tearing their hair from the root. While some monsters were more solitary than others, all of them were possessive of what they deemed their family —pack.

Ghost and König stuck closer during training, a tall, imposing figure behind you that acted as a guard dog to ward away anyone they deemed a danger. Soap and Horangi hung around you in the rec room, either laying on you or clinging to you, putting a show of ownership over you. Rudy and Alejandro, the ever active couple, were always finding you around the base, striking up a conversation and wrapping their arms around you. Gaz would was the cuddliest of the group, finding time outside of his busy to snuggle up against you and cover you with his wings, pulling you to sleep on his shoulder. Price, the man with the most authority in the TF made sure that you were always with someone on every Op, having someone to back you up in the most dire situation.

Every visit to the medic made them wild, it brought them closer to desperate measures. Would it be so bad to turn you in one? Would it be so bad to let Soap bite you during the full moon, his bite infecting you with his power: thicker skin, sturdier build, longer lifespan and better sense? The only draw backs were the higher wildness, near feral during full moons and a competitive mindset over the possessiveness and brattiness of a young werewolf.

Would it be so bad to make you return as a wraith? While Ghost learned to control his powers alone, the pain and emotions building up in his body without any way of letting it out, you had him, you wouldn’t be alone with the resurrection. He didn’t want you to feel the terror and agony by yourself —he didn’t want you to know how it felt to die and come back.

Would it be so bad to have a vampire turn you into one without becoming a thrall? You couldn’t walk in the sun, something you told them you enjoyed, you’d be restrained to specific activities and you wouldn’t like that, being limited by the sun. Granted, there were solutions to that, but none very comfortable.

They knew you were aware of your mortality, made fun of it and laughed as it this was your last day, but you didn’t fear death, you only feared leaving them. You were open to their thoughts, listening to their ideas and options with a neutral expression, but you didn’t reject the idea of turning you. That was a good thing, a step forward in their mind.

Now all that needed to do was to let you decide which path you wanted to walk.

tag list: @craxy-person @crowbird @dead-cipher @iwannabealocalcryptid @iizx7y @mxtokko @yeetusspagheetus @capricorn-anon @perfectus-in-morte @sae1kie @yeoldedumbslut @tallmanlover @distracteddragoness @vxnilla-hxrddrugs @konigsblog @havoc973 @angelcakes-22 @cassiecasluciluce @ramadiiiisme @ramblingsofachaoticthinker @ki-cant-spel

1K notes · View notes

the-boring-distopia · 4 months ago

Text

I love the Locked Tomb series, when the Third were introduced I was seriously thinking that the reason Ianthe was so thin and sick was prion disease. You know, from munching on people. This was one of my original headcanons, I honestly thought I was one step ahead the plot until the finale happened.

Even if it's not the case, I'm still curious how Third necromancers avoid getting it.

This is kind of a theory post but bare with me.

(cw: cannibalism, illness)

There is a prion disease called Kuru that spreads via cannibalism, especially by eating the brain. But there are other prion diseases that a person can get infected with and they spread by consumption of meat or coming into contact with an infected animal. In this post we assume that the most common of these diseases in the Locked Tomb universe would be Kuru, because of all that cannibalism, we can also assume that it can be inherited from the mother.

This would have heavy and fairly interesting social consequences on the Third:

There is not really a treatment. If you get it, you have it, forever - unless the necromancers found a solution in the last ten thousand years. But even if they did invent a cure, being a cavalier and having it is probably a career ender, because no necromancer would risk catching an illness that could destroy their brain on top of being physically weak and frail. That means that people who have it are most likely shunned or avoided, depending on how authorian Ida is the individuals might be restricted or marked in a database. It can be passed down from mother to child and the nine houses care a lot about health and genetics, it's not impossible that they might limit an individuals ability to have children if they are infected.

Prion diseases are difficult to keep track of because they have a long incubation period when the host does not experience any troubles, and then it's either long, consistent decay or instant critical condition. It's kind of like rabies in a sense that preventing it is the first line of defense. In a society where a large number of people regularly consume human tissues there are probably insane regulations. With necromancy almost being a religious ritual there is probably a body in the government that tracks cav-necro pairs and runs tests on them regularly to make sure they are healthy. Wanna go to space? Health check. You wish to join the royal guard? Health check. You just arrived from the sixth and hope to see the Idan library? You guessed it: quarantine and health check.

The main danger of prion diseases is mental decline, brain problems, memory loss, seizures and loss of motor control. Statistically a number of necromancers would get it despite the regulations, and they would experience Alzheimers like symptoms, insomnia, terrible headaches and their self-regulatory systems shutting down (no longer feeling hungry or tired because of brain damage). Human society has a terrible track record with mental illness, we did things to people in the past that are worse than death. How would a society like Ida deal with a crisis of their necromancers (and most likely their children) deteriorating into corpses? Would there be care homes? Institutions? Would they be declared a danger and "disposed of"? This would also make every necromancer from Ida suspicious to other houses where this kind of cannibalism is not common: they are a liability. Imagine the stress of being a necromancer from Ida and getting a terrible headache one morning, you feel groggy and slow, and instead of knowing this is one of those days you fear for your life because what if you somehow got infected? What if someone poisoned you? If you have political opponents, it's not even that far off. The government can probably accuse you of showing symptoms and remove you from the public eye, forever, if you speak up against them.

And as a last thing: with the risks listed, the whole thing is probably not worth it, unless Jod somehow gave them magical immunity against it. It would cost money, time, resources to test all these people when the simpler solution is just, not eating the flesh of other people? Hair and nails are probably fine, but flesh? No.

In conclusion, cannibalism is a perfect metafor for supressed lesbian yearning but from a technical standpoint it would be a pain in the ass.

#tlt #the locked tomb #ianthe tridentarius #theory posting #I am turning the canon in my hand as if it's a magical orb I'm pondering #it's just a theory

153 notes · View notes